Amgen Set to Showcase Innovations at 46th Annual TD Cowen Health Care Conference

Amgen, a global leader in biotechnology, is excited to announce its participation in the upcoming 46th Annual TD Cowen Health Care Conference taking place on March 2, 2026. This significant event will feature key insights from Amgen's senior executives, including Kave Niksefat, Senior Vice President of Global Marketing and Access, and Justin Claeys, Senior Vice President of Finance.

Scheduled for 1:10 p.m. ET, the presentation will be available for live streaming, allowing media representatives, investors, and the general public to engage with the latest developments in Amgen's innovative healthcare solutions. The webcast will not only offer real-time updates but will also be archived for later viewing, ensuring accessibility for those who might miss the live presentation.

Amgen has a rich history in the biotechnology field, having played a pivotal role in establishing the industry over 45 years ago in Thousand Oaks, California. The company is renowned for utilizing the synergy of biology and technology to create and deliver groundbreaking therapies targeting some of the world’s most challenging diseases, including cancer, heart disease, and certain rare conditions.

As part of its commitment to innovation, Amgen continuously invests in research and development, driven by human genetic data and technological advancements. This relentless pursuit of knowledge and improvement has positioned Amgen at the forefront of the biotechnology sector, making it a significant player in the landscape of modern medicine.

In addition to its technological strides, Amgen is celebrated for its workplace culture and ethical business practices, receiving accolades from reputable organizations like Fast Company and Forbes. This recognition underscores Amgen's commitment not just to scientific progress but also to fostering an inclusive and innovative workplace.

As a constituent of the Dow Jones Industrial Average and the Nasdaq-100 Index, Amgen is recognized among the most influential and innovative companies listed on the stock market. This representation emphasizes Amgen's crucial role in the global healthcare narrative, as the company continues to strive towards helping millions of patients worldwide.

With the upcoming conference providing a platform for dialogue and insight, Amgen is poised to further engage with its stakeholders and the community at large. Those interested can access the live webcast, along with previous presentations, by visiting Amgen's Investor Relations page at www.amgen.com where details on presentation times and links are readily available.

Through its mission, Amgen not only advances medical science and patient care but also serves as a beacon of hope for millions grappling with health challenges across the globe. As Amgen looks towards the future, its dedication to improving lives through innovation remains unwavering, promising exciting developments in the biotechnology landscape ahead.

For more updates, follow Amgen on various social media platforms, including X, LinkedIn, Instagram, YouTube, Facebook, TikTok, and Threads, ensuring you stay informed on their latest breakthroughs and community engagement initiatives.